Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DECISIve - DiagnosE Using the Central veIn SIgn. A Prospective Diagnostic Superiority Study Comparing T2* MRI and Lumbar Puncture in Patients Presenting With Possible Multiple Sclerosis

NCT04024969 is registered in ClinicalTrials.gov with Nottingham University Hospitals NHS Trust as lead sponsor.

NCT NCT04024969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04024969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DECISIve - DiagnosE Using the Central veIn SIgn. A Prospective Diagnostic Superiority Study Comparing T2* MRI and Lumbar Puncture in Patients Presenting With Possible Multiple Sclerosis
Lead sponsor
Nottingham University Hospitals NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
November 6, 2019
Completion date
November 30, 2022
Enrollment
115 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis